nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—psoriasis—systemic scleroderma	0.859	1	CtDrD
Tazarotene—CYP2C8—Mometasone—systemic scleroderma	0.0677	0.715	CbGbCtD
Tazarotene—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0269	0.285	CbGbCtD
Tazarotene—Sensitisation—Mometasone—systemic scleroderma	0.0028	0.0614	CcSEcCtD
Tazarotene—Leukoderma—Mometasone—systemic scleroderma	0.00235	0.0516	CcSEcCtD
Tazarotene—Cheilitis—Mycophenolic acid—systemic scleroderma	0.00162	0.0356	CcSEcCtD
Tazarotene—Cheilitis—Mycophenolate mofetil—systemic scleroderma	0.00128	0.0281	CcSEcCtD
Tazarotene—Stinging—Mometasone—systemic scleroderma	0.00123	0.0271	CcSEcCtD
Tazarotene—Blister—Captopril—systemic scleroderma	0.00122	0.0267	CcSEcCtD
Tazarotene—Skin discolouration—Mometasone—systemic scleroderma	0.00111	0.0243	CcSEcCtD
Tazarotene—Dermatitis contact—Mometasone—systemic scleroderma	0.000987	0.0217	CcSEcCtD
Tazarotene—Swelling—Pentoxifylline—systemic scleroderma	0.000952	0.0209	CcSEcCtD
Tazarotene—Leukoderma—Prednisone—systemic scleroderma	0.000868	0.019	CcSEcCtD
Tazarotene—Acne—Leflunomide—systemic scleroderma	0.000859	0.0189	CcSEcCtD
Tazarotene—Acne—Mycophenolic acid—systemic scleroderma	0.00082	0.018	CcSEcCtD
Tazarotene—Skin discolouration—Leflunomide—systemic scleroderma	0.0008	0.0176	CcSEcCtD
Tazarotene—Inflammation—Leflunomide—systemic scleroderma	0.000745	0.0164	CcSEcCtD
Tazarotene—Leukoderma—Methotrexate—systemic scleroderma	0.000725	0.0159	CcSEcCtD
Tazarotene—Dermatitis contact—Leflunomide—systemic scleroderma	0.000715	0.0157	CcSEcCtD
Tazarotene—Dermatitis bullous—Captopril—systemic scleroderma	0.000666	0.0146	CcSEcCtD
Tazarotene—Acne—Mycophenolate mofetil—systemic scleroderma	0.000647	0.0142	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Prednisone—systemic scleroderma	0.000642	0.0141	CcSEcCtD
Tazarotene—Skin discolouration—Mycophenolate mofetil—systemic scleroderma	0.000603	0.0132	CcSEcCtD
Tazarotene—Haemoglobin—Pentoxifylline—systemic scleroderma	0.000584	0.0128	CcSEcCtD
Tazarotene—Eczema—Leflunomide—systemic scleroderma	0.000584	0.0128	CcSEcCtD
Tazarotene—Haemorrhage—Pentoxifylline—systemic scleroderma	0.000581	0.0128	CcSEcCtD
Tazarotene—Swelling—Mycophenolic acid—systemic scleroderma	0.000568	0.0125	CcSEcCtD
Tazarotene—Blood triglycerides increased—Prednisone—systemic scleroderma	0.000563	0.0124	CcSEcCtD
Tazarotene—Dermatitis bullous—Mycophenolic acid—systemic scleroderma	0.000524	0.0115	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methotrexate—systemic scleroderma	0.000518	0.0114	CcSEcCtD
Tazarotene—Erythema—Pentoxifylline—systemic scleroderma	0.000506	0.0111	CcSEcCtD
Tazarotene—Photosensitivity reaction—Captopril—systemic scleroderma	0.000502	0.011	CcSEcCtD
Tazarotene—Eczema—Lisinopril—systemic scleroderma	0.000502	0.011	CcSEcCtD
Tazarotene—Dry skin—Leflunomide—systemic scleroderma	0.000481	0.0106	CcSEcCtD
Tazarotene—Burning sensation—Methotrexate—systemic scleroderma	0.000444	0.00974	CcSEcCtD
Tazarotene—Acne—Prednisone—systemic scleroderma	0.000439	0.00962	CcSEcCtD
Tazarotene—Discomfort—Pentoxifylline—systemic scleroderma	0.000426	0.00934	CcSEcCtD
Tazarotene—Dermatitis bullous—Mycophenolate mofetil—systemic scleroderma	0.000413	0.00907	CcSEcCtD
Tazarotene—Oedema—Pentoxifylline—systemic scleroderma	0.000413	0.00906	CcSEcCtD
Tazarotene—Haemoglobin—Azathioprine—systemic scleroderma	0.000386	0.00848	CcSEcCtD
Tazarotene—Haemorrhage—Azathioprine—systemic scleroderma	0.000384	0.00844	CcSEcCtD
Tazarotene—Haemoglobin—Leflunomide—systemic scleroderma	0.000365	0.00801	CcSEcCtD
Tazarotene—Haemorrhage—Leflunomide—systemic scleroderma	0.000363	0.00797	CcSEcCtD
Tazarotene—Oedema peripheral—Leflunomide—systemic scleroderma	0.000358	0.00785	CcSEcCtD
Tazarotene—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.000356	0.00781	CcSEcCtD
Tazarotene—Skin exfoliation—Prednisone—systemic scleroderma	0.000352	0.00773	CcSEcCtD
Tazarotene—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.000348	0.00764	CcSEcCtD
Tazarotene—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.000346	0.0076	CcSEcCtD
Tazarotene—Skin discolouration—Methotrexate—systemic scleroderma	0.000341	0.00749	CcSEcCtD
Tazarotene—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.000341	0.00749	CcSEcCtD
Tazarotene—Discomfort—Captopril—systemic scleroderma	0.000323	0.00708	CcSEcCtD
Tazarotene—Inflammation—Methotrexate—systemic scleroderma	0.000318	0.00698	CcSEcCtD
Tazarotene—Oedema peripheral—Lisinopril—systemic scleroderma	0.000307	0.00674	CcSEcCtD
Tazarotene—Pain—Mometasone—systemic scleroderma	0.000305	0.00669	CcSEcCtD
Tazarotene—Skin exfoliation—Methotrexate—systemic scleroderma	0.000294	0.00646	CcSEcCtD
Tazarotene—Pruritus—Pentoxifylline—systemic scleroderma	0.000292	0.00641	CcSEcCtD
Tazarotene—Discomfort—Azathioprine—systemic scleroderma	0.000282	0.00618	CcSEcCtD
Tazarotene—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000275	0.00603	CcSEcCtD
Tazarotene—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000273	0.006	CcSEcCtD
Tazarotene—Erythema—Lisinopril—systemic scleroderma	0.000272	0.00596	CcSEcCtD
Tazarotene—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000269	0.00591	CcSEcCtD
Tazarotene—Discomfort—Leflunomide—systemic scleroderma	0.000266	0.00583	CcSEcCtD
Tazarotene—Rash—Pentoxifylline—systemic scleroderma	0.00026	0.00571	CcSEcCtD
Tazarotene—Dermatitis—Pentoxifylline—systemic scleroderma	0.00026	0.00571	CcSEcCtD
Tazarotene—Discomfort—Mycophenolic acid—systemic scleroderma	0.000254	0.00557	CcSEcCtD
Tazarotene—Pruritus—Mometasone—systemic scleroderma	0.000252	0.00553	CcSEcCtD
Tazarotene—Oedema—Mycophenolic acid—systemic scleroderma	0.000246	0.0054	CcSEcCtD
Tazarotene—Dry skin—Prednisone—systemic scleroderma	0.000246	0.00539	CcSEcCtD
Tazarotene—Discomfort—Lisinopril—systemic scleroderma	0.000228	0.00501	CcSEcCtD
Tazarotene—Rash—Mometasone—systemic scleroderma	0.000225	0.00493	CcSEcCtD
Tazarotene—Dermatitis—Mometasone—systemic scleroderma	0.000224	0.00493	CcSEcCtD
Tazarotene—Oedema—Lisinopril—systemic scleroderma	0.000222	0.00486	CcSEcCtD
Tazarotene—Pruritus—Captopril—systemic scleroderma	0.000221	0.00486	CcSEcCtD
Tazarotene—Pain—Leflunomide—systemic scleroderma	0.000221	0.00484	CcSEcCtD
Tazarotene—Pain—Mycophenolic acid—systemic scleroderma	0.00021	0.00462	CcSEcCtD
Tazarotene—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.0002	0.00439	CcSEcCtD
Tazarotene—Rash—Captopril—systemic scleroderma	0.000197	0.00433	CcSEcCtD
Tazarotene—Dermatitis—Captopril—systemic scleroderma	0.000197	0.00433	CcSEcCtD
Tazarotene—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000194	0.00426	CcSEcCtD
Tazarotene—Pain—Lisinopril—systemic scleroderma	0.00019	0.00416	CcSEcCtD
Tazarotene—Haemoglobin—Prednisone—systemic scleroderma	0.000186	0.00409	CcSEcCtD
Tazarotene—Haemorrhage—Prednisone—systemic scleroderma	0.000185	0.00407	CcSEcCtD
Tazarotene—Pruritus—Leflunomide—systemic scleroderma	0.000183	0.004	CcSEcCtD
Tazarotene—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000177	0.00387	CcSEcCtD
Tazarotene—Pruritus—Mycophenolic acid—systemic scleroderma	0.000174	0.00382	CcSEcCtD
Tazarotene—Rash—Azathioprine—systemic scleroderma	0.000172	0.00378	CcSEcCtD
Tazarotene—Dermatitis—Azathioprine—systemic scleroderma	0.000172	0.00378	CcSEcCtD
Tazarotene—Pain—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00364	CcSEcCtD
Tazarotene—Rash—Leflunomide—systemic scleroderma	0.000163	0.00357	CcSEcCtD
Tazarotene—Dermatitis—Leflunomide—systemic scleroderma	0.000162	0.00357	CcSEcCtD
Tazarotene—Erythema—Prednisone—systemic scleroderma	0.000161	0.00354	CcSEcCtD
Tazarotene—Pruritus—Lisinopril—systemic scleroderma	0.000157	0.00344	CcSEcCtD
Tazarotene—Haemoglobin—Methotrexate—systemic scleroderma	0.000156	0.00342	CcSEcCtD
Tazarotene—Rash—Mycophenolic acid—systemic scleroderma	0.000155	0.0034	CcSEcCtD
Tazarotene—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000155	0.0034	CcSEcCtD
Tazarotene—Haemorrhage—Methotrexate—systemic scleroderma	0.000155	0.0034	CcSEcCtD
Tazarotene—RARG—skin of body—systemic scleroderma	0.000153	0.126	CbGeAlD
Tazarotene—RARB—tendon—systemic scleroderma	0.000143	0.118	CbGeAlD
Tazarotene—Rash—Lisinopril—systemic scleroderma	0.00014	0.00307	CcSEcCtD
Tazarotene—Dermatitis—Lisinopril—systemic scleroderma	0.00014	0.00306	CcSEcCtD
Tazarotene—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000137	0.00301	CcSEcCtD
Tazarotene—Discomfort—Prednisone—systemic scleroderma	0.000136	0.00298	CcSEcCtD
Tazarotene—Erythema—Methotrexate—systemic scleroderma	0.000135	0.00296	CcSEcCtD
Tazarotene—Oedema—Prednisone—systemic scleroderma	0.000132	0.00289	CcSEcCtD
Tazarotene—RXRB—tendon—systemic scleroderma	0.000131	0.108	CbGeAlD
Tazarotene—RARB—lung—systemic scleroderma	0.000125	0.103	CbGeAlD
Tazarotene—RARG—digestive system—systemic scleroderma	0.000123	0.101	CbGeAlD
Tazarotene—Rash—Mycophenolate mofetil—systemic scleroderma	0.000122	0.00269	CcSEcCtD
Tazarotene—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000122	0.00268	CcSEcCtD
Tazarotene—RARG—tendon—systemic scleroderma	0.000117	0.0959	CbGeAlD
Tazarotene—RXRB—lung—systemic scleroderma	0.000115	0.0948	CbGeAlD
Tazarotene—Discomfort—Methotrexate—systemic scleroderma	0.000113	0.00249	CcSEcCtD
Tazarotene—RARA—tendon—systemic scleroderma	0.00011	0.0902	CbGeAlD
Tazarotene—RARG—lung—systemic scleroderma	0.000102	0.0842	CbGeAlD
Tazarotene—RARA—lung—systemic scleroderma	9.62e-05	0.0792	CbGeAlD
Tazarotene—Pain—Methotrexate—systemic scleroderma	9.41e-05	0.00206	CcSEcCtD
Tazarotene—Pruritus—Prednisone—systemic scleroderma	9.31e-05	0.00204	CcSEcCtD
Tazarotene—Rash—Prednisone—systemic scleroderma	8.3e-05	0.00182	CcSEcCtD
Tazarotene—Dermatitis—Prednisone—systemic scleroderma	8.29e-05	0.00182	CcSEcCtD
Tazarotene—Pruritus—Methotrexate—systemic scleroderma	7.78e-05	0.00171	CcSEcCtD
Tazarotene—Rash—Methotrexate—systemic scleroderma	6.94e-05	0.00152	CcSEcCtD
Tazarotene—Dermatitis—Methotrexate—systemic scleroderma	6.93e-05	0.00152	CcSEcCtD
